NCT05864547 Predisposing Factors for Post-stroke Epilepsy
| NCT ID | NCT05864547 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Norwegian University of Science and Technology |
| Condition | Post Stroke Epilepsy |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2023-05-08 |
| Primary Completion | 2030-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2023-05-08 with a primary completion date of 2030-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to learn about epilepsy after a stroke (post-stroke epilepsy). The main questions it aims to answer are: * What make some patients develop epilepsy after a stroke? * Does sleep have an impact on the development of post-stroke epilepsy? Participants will undergo: * Electroencephalography (EEG) * Magnetic resonance imaging (MRI) * Polysomnography (only patients) Blood tests will also be taken. The patient group will be compared to the healthy controls. Researchers will also look into medical records of stroke patients hospitalized at St. Olavs hospital and collect relevant information.
Eligibility Criteria
Inclusion Criteria: * First time stroke patients with capacity to consent, admitted to the stroke unit at St. Olavs hospital. * Modified Rankin Scale (mRS) ≤ 2 before the stroke Exclusion Criteria: * Previous stroke or brain surgery * Traumatic brain injuries * Neurodegenerative diseases * Brain tumors * Epilepsy before the stroke * Hydrocephalus * Aphasia * Serious psychiatric disorders * MRI incompatibility and claustrophobia
Contact & Investigator
Axel Sandvig, PhD prof
PRINCIPAL INVESTIGATOR
Norwegian Science and Technology University
Frequently Asked Questions
Who can join the NCT05864547 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Post Stroke Epilepsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05864547 currently recruiting?
Yes, NCT05864547 is actively recruiting participants. Contact the research team at axel.sandvig@ntnu.no for enrollment information.
Where is the NCT05864547 trial being conducted?
This trial is being conducted at Trondheim, Norway.
Who is sponsoring the NCT05864547 clinical trial?
NCT05864547 is sponsored by Norwegian University of Science and Technology. The principal investigator is Axel Sandvig, PhD prof at Norwegian Science and Technology University. The trial plans to enroll 30 participants.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.